Barclays PLC (LSE:BARC) has a problem in its US credit cards following the ending of its decade-long partnership with American Airlines.
The US carrier announced yesterday that Citi will be its new exclusive co-branded credit card partner via a ten-year partnership.
Shares of Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) rose in afternoon trading after the company announced a $10 million fundraising commitment from its largest investor, AOP Health International.
AOP will purchase new shares at 3p each, slightly above the previous day’s closing price.
UBS analysts believe now is the time to invest in BP PLC (LSE:BP.), highlighting the stock's undervalued position and potential for recovery.
A 19% year-to-date decline, far steeper than Shell’s 3% drop or Chevron’s 6% gain, suggests the stock may be oversold and the Swiss bank sees BP's February strategy update as a pivotal moment to address investor concerns and reset its trajectory.